HSP90B2P and breast carcinoma: The present study confirmed that interventional RFH can promote HSP promoter-mediated TK suicide gene transfection and expression in chemotherapeutic-resistant breast cancers, thereby enhancing the efficacy of TK/GCV gene therapy.